Department of Medicine and Optometry, Linnaeus University, Kalmar, Sweden.
Low Vision and Visual Rehabilitation Lab, Department and Center of Physics - Optometry and Vision Science, University of Minho, Braga, Portugal.
BMJ Open. 2022 Sep 8;12(9):e056995. doi: 10.1136/bmjopen-2021-056995.
The aim of this study was to estimate the prevalence and causes of vision impairment (VI) in Portugal.
Information about people with VI was obtained from primary care centres, blind association (ACAPO) and from hospitals (the PCVIP study) in the Northwest of Portugal during a period spanning years 2014-2015. Causes of VI were obtained from hospitals.
Administrative and medical records of people with visual acuity in the better seeing eye of 0.5 decimal (0.30logMAR) or worse and/or visual field less than 20° were investigated. Capture-recapture with log-linear models was applied to estimate the number of individuals missing from lists of cases obtained from available sources.
Log-linear models were used to estimate the crude prevalence and the category specific prevalence of VI.
Crude prevalence of VI was 1.97% (95% CI 1.56% to 2.54%), and standardised prevalence was 1% (95% CI 0.78% to 1.27%). The age-specific prevalence was 3.27% (95% CI 2.36% to 4.90%), older than 64 years, 0.64% (95% CI 0.49% to 0.88%), aged 25-64 years, and 0.07% (95% CI 0.045% to 0.13%), aged less than 25 years. The female-to-male ratio was 1.3, that is, higher prevalence among females. The five leading causes of VI were diabetic retinopathy, cataract, age-related macular degeneration, glaucoma and disorders of the globe.
The prevalence of VI in Portugal was within the expected range and in line with other European countries. A significant number of cases of VI might be due to preventable cases and, therefore, a reduction of the prevalence of VI in Portugal seems possible. Women and old people were more likely to have VI and, therefore, these groups require extra attention. Future studies are necessary to characterise temporal changes in prevalence of VI in Portugal.
本研究旨在评估葡萄牙视力障碍(VI)的患病率和病因。
2014-2015 年期间,在葡萄牙西北部的初级保健中心、盲人协会(ACAPO)和医院(PCVIP 研究)收集有关 VI 患者的信息。病因信息则来自医院。
研究调查了视力较好眼视力为 0.5 十进制(0.30logMAR)或更差和/或视野小于 20°的人群的行政和医疗记录。应用捕获-再捕获对数线性模型来估计从可用来源获得的病例清单中缺失的人数。
对数线性模型用于估计 VI 的粗患病率和特定类别患病率。
VI 的粗患病率为 1.97%(95%CI 1.56%至 2.54%),标准化患病率为 1%(95%CI 0.78%至 1.27%)。年龄特异性患病率为 3.27%(95%CI 2.36%至 4.90%),64 岁以上人群患病率为 0.64%(95%CI 0.49%至 0.88%),25-64 岁人群患病率为 0.07%(95%CI 0.045%至 0.13%),25 岁以下人群患病率为 0.07%(95%CI 0.045%至 0.13%)。女性与男性的比例为 1.3,即女性的患病率更高。导致 VI 的五个主要原因是糖尿病视网膜病变、白内障、年龄相关性黄斑变性、青光眼和眼球疾病。
葡萄牙 VI 的患病率处于预期范围内,与其他欧洲国家一致。大量 VI 病例可能是可预防的,因此葡萄牙 VI 的患病率有可能降低。女性和老年人更容易患有 VI,因此这些人群需要特别关注。未来的研究有必要描述葡萄牙 VI 患病率的时间变化。